IBX
Click for more information
35.0% 5.4¢ imagion biosystems limited

Ann: FDA Breakthrough Device Designation, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. yesitsme
    3,193 Posts.
    lightbulb Created with Sketch. 56
    clock Created with Sketch.
    18/07/19
    14:27
    Post #: 39582926
    Sure there be lot of news to follow
    IBX Price at posting: 6.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
NEWS High-grade copper-gold at Mt Isa North—grab samples hit up to 30% Cu and more, with drilling set to begin
right-arrow Created with Sketch.
NEWS Major acquisition of high-grade antimony deposit, find out who's securing global assets
right-arrow Created with Sketch.
LU7 Strong preliminary feasibility for Bécancour Lithium Refinery
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS New insights revealed: high-grade lode gold/copper deposit model for El Dovio Project reinterpreted—see the potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
5.4¢ 		Change
0.014(35.0%) 		Mkt cap ! $1.924M
Open High Low Value Volume
4.0¢ 6.8¢ 4.0¢ $120.8K 2.200M

Buyers (Bids)

No. Vol. Price($)
1 6767 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 210923 1
View Market Depth
Last trade - 15.56pm 01/10/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.